Sarah Kim
Primary Care · Cary, NCNPI 1154954154
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,054 and has fallen 97.6% since, to $26 in 2025.
Across 174 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$294
- Lilly USA, LLC$252
- Medtronic$236
- Xeris Pharmaceuticals, Inc.$197
- Dexcom, Inc.$174
- AstraZeneca$173
- plus $2K from 29 others
What the payments were for
- Food & beverage$2,972100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $294 |
| Lilly USA, LLC | 17 | $252 |
| Medtronic | 18 | $236 |
| Xeris Pharmaceuticals, Inc. | 10 | $197 |
| Dexcom, Inc. | 9 | $174 |
| AstraZeneca(2 entities) | 10 | $173 |
| Corcept Therapeutics | 8 | $162 |
| AbbVie | 8 | $127 |
| Radius Health, Inc. | 5 | $119 |
| Insulet Corporation | 4 | $117 |
| Esperion Therapeutics, Inc. | 5 | $103 |
| Merck | 6 | $97 |
| Bayer | 4 | $87 |
| IBSA Pharma Inc. | 5 | $84 |
| Vivus LLC | 5 | $76 |
| Sanofi-aventis U.S. LLC | 5 | $74 |
| Antares Pharma, Inc. | 4 | $72 |
| Boston Scientific | 2 | $67 |
| Boehringer Ingelheim | 3 | $52 |
| Lifescan, Inc. | 2 | $51 |
| Novartis | 3 | $41 |
| Tandem Diabetes Care, Inc. | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $37 |
| Endo Pharmaceuticals Inc. | 2 | $37 |
| Amgen | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Nestle Healthcare Nutrition Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| BD | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Mannkind Corporation | 1 | $11 |
How this compares
$2,985 in reported general payments places this provider in the 85th percentile of 236 primary care providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 16 | $27,985 |
| JardianceEmpagliflozin | 11 | $12,259 |
| SynthroidLevothyroxine Sodium | 15 | $1,821 |
| Levothyroxine Sodium | 52 | $726 |
| Metformin Hcl ErMetformin Hcl | 20 | $203 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $294 | $27,98516 claims |
| Boehringer IngelheimJardiance | $52 | $12,25911 claims |
| AbbVieSynthroid | $127 | $1,82115 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $72652 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 236 primary care providers in North Carolina.
Other primary care in Cary
- Heidi ScronceCary$2K
- Jessica AllynRaleigh$21K
- Jennifer RogersWinston Salem$17K
- Elizabeth WaltersChapel Hill$14K
- Ragan JohnsonChapel Hill$13K
- Kirkland DickeyPine Hall$11K
- Kimberly WeaverHickory$9K
- Amanda StoneWilmington$9K
- Elizabeth WalshGreensboro$7K
- Mark HollingsworthWilmington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.